Skip to main content Skip to section navigation Skip to footer
Relmada Therapeutics, Inc.
  • Home
  • Relmada Therapeutics, Inc.
  • Our story
  • Our focus
  • Our portfolio
    • Pipeline
    • REL-1017
    • Expanded Access Program (EAP) policy
    • Data and publications
  • For investors
    • Company
    • Stock
    • SEC filings
    • Governance
    • Analysts
    • News
    • Events
  • Contact us
  • Sign up for email alerts
Contact us
For investors

For investors

  • Company
  • Stock
  • SEC filings
  • Governance
  • Analysts
  • News
  • Events

Stock information

  • Stock quote
  • Historical data

Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Sign up for alerts
  • Our story
  • Our focus
  • Our portfolio
    • Pipeline
    • REL-1017
    • Expanded Access Program (EAP) policy
    • Data and publications
  • For investors
    • Company
    • Stock
    • SEC filings
    • Governance
    • Analysts
    • News
    • Events
  • Contact us
    • info@relmada.com
    • +1 (786) 629-1376
Relmada Therapeutics, Inc.
©2023 Relmada Therapeutics, Inc.